Lipid Metabolism Compound Library: Tools for Metabolic Research
Lipid Metabolism Compound Library: Tools for Metabolic Research
Lipid Metabolism Compound Library is a curated collection of bioactive small molecules specifically selected to modulate key enzymes, receptors, and regulatory proteins involved in lipid biosynthesis, catabolism, transport, and signaling pathways.
- Product Name
- Lipid Metabolism Compound Library
- SKU
- Lib412096
- Selleck Reference Number
- L9200
- Primary Application
- Lipid pathway modulation, drug discovery screening, metabolic disease research
- Compound Format
- Bioactive small molecules supplied as a pre-plated or solution-format library
- Research Areas
- Obesity, diabetes, cardiovascular disease, non-alcoholic fatty liver disease (NAFLD), atherosclerosis
What Is the Lipid Metabolism Compound Library?
The Lipid Metabolism Compound Library (Lib412096) is a specialized collection of bioactive small molecules curated to target the principal nodes of lipid metabolism. Lipid metabolism encompasses the synthesis, degradation, storage, and transport of fatty acids, triglycerides, phospholipids, sphingolipids, sterols, and their derivatives — all of which are central to cellular energy homeostasis and membrane integrity.
Each compound in this library has been selected on the basis of documented biological activity against enzymes, receptors, or regulatory proteins known to participate in lipid metabolic pathways. The library is designed to accelerate both basic mechanistic studies and translational drug-discovery programs targeting metabolic disorders.
Key Lipid Metabolism Pathways Targeted
The compounds within the Lipid Metabolism Compound Library collectively address several interconnected metabolic pathways:
- Fatty acid synthesis and oxidation: Modulators of fatty acid synthase (FASN), acetyl-CoA carboxylase (ACC), and carnitine palmitoyltransferase (CPT) allow researchers to dissect the balance between lipid anabolism and catabolism.
- Cholesterol and sterol metabolism: Inhibitors and activators targeting HMG-CoA reductase, PCSK9, and related enzymes in the mevalonate pathway are represented, supporting cardiovascular and atherosclerosis research.
- Sphingolipid and glycerophospholipid signaling: Small molecules affecting ceramide synthase, sphingosine kinase, and phospholipase activity enable studies of lipid-mediated signal transduction.
- Lipoprotein assembly and transport: Compounds modulating apolipoprotein function, ABCA1-dependent cholesterol efflux, and lipid transfer proteins facilitate lipoprotein biology investigations.
- Lipid droplet dynamics and autophagy: Regulators of lipophagy and lipid droplet biogenesis provide tools for studying ectopic lipid accumulation relevant to NAFLD and obesity.
This multi-pathway coverage makes the library particularly valuable for phenotypic screening campaigns where the precise molecular target may not yet be established.
Applications in Drug Discovery and Disease Research
The Lipid Metabolism Compound Library serves a broad range of experimental applications:
High-throughput and high-content screening (HTS/HCS): The library format is compatible with 96- and 384-well plate assay systems, enabling rapid profiling of compound effects on lipid accumulation, enzyme activity, or reporter gene expression in cellular models. Lipid-specific fluorescent probes such as BODIPY-fatty acid analogs or filipin for cholesterol detection are commonly co-deployed in these assays.
Target identification and validation: When combined with chemoproteomics, thermal proteome profiling (TPP), or CRISPR-based genetic screens, compounds from the library can pinpoint novel lipid-metabolism targets relevant to disease phenotypes.
Metabolic disease models: The library is widely used in in vitro models of obesity (3T3-L1 adipocytes), type 2 diabetes (insulin-resistant hepatocytes), NAFLD (lipid-laden HepG2 or primary hepatocytes), and cardiovascular disease (macrophage foam-cell formation assays).
Mechanistic studies: Individual compounds or sub-libraries can be used to probe pathway crosstalk, for example between lipid metabolism and inflammatory signaling (NF-κB, NLRP3 inflammasome) or mTOR-mediated nutrient sensing.
Practical Guidance: Screening Setup and Quality Considerations
To obtain reproducible and biologically meaningful results with the Lipid Metabolism Compound Library, researchers should consider the following best practices:
Solvent and concentration: Most small-molecule libraries are supplied dissolved in DMSO. Final DMSO concentration in assay wells should be kept at or below 0.1–0.5% to avoid cytotoxicity artefacts, particularly in lipid-metabolism assays where membrane fluidity may be affected. Conduct a DMSO-only vehicle control in every plate.
Cell model selection: Choose a cell line or primary cell type that authentically recapitulates the lipid-metabolism phenotype of interest. Hepatocyte-derived lines, adipocyte differentiation models, and macrophage systems each present distinct lipid-handling characteristics.
Positive and negative controls: Include well-characterized reference compounds with known mechanism of action (e.g., a statin for HMG-CoA reductase inhibition) as intra-plate positive controls to calculate Z′-factor and monitor assay robustness across plates.
Counter-screens for cytotoxicity: Any hit compound should be counter-screened for general cytotoxicity (e.g., via ATP-based viability assays) to distinguish specific metabolic effects from non-specific cell death.
Storage and handling: Compound libraries should be stored according to the supplier's recommendations, typically at −20 °C or −80 °C under desiccated, light-protected conditions. Avoid repeated freeze-thaw cycles to preserve compound integrity and potency.
Frequently asked questions
What types of compounds are included in the Lipid Metabolism Compound Library?
The library contains bioactive small molecules with documented activity against targets involved in lipid metabolism, including inhibitors and activators of enzymes in fatty acid synthesis and oxidation, cholesterol biosynthesis, sphingolipid metabolism, and lipoprotein transport pathways. The precise number and identity of compounds should be confirmed with the current product datasheet, as library composition may be updated.
Is the Lipid Metabolism Compound Library suitable for high-throughput screening?
Yes. The library format is designed to be compatible with standard 96-well and 384-well microplate formats commonly used in high-throughput screening (HTS) and high-content screening (HCS) platforms. Researchers should verify exact plate format, volume, and concentration specifications with the current datasheet prior to assay setup.
How should the Lipid Metabolism Compound Library be stored to maintain compound stability?
Compound libraries dissolved in DMSO should generally be stored at −20 °C or −80 °C under desiccated, light-protected conditions. Repeated freeze-thaw cycles should be minimized to preserve compound integrity and potency. Always refer to the specific storage instructions provided on the product datasheet for authoritative guidance.
Can the Lipid Metabolism Compound Library be used to study non-alcoholic fatty liver disease (NAFLD)?
Yes, the library is well-suited for NAFLD research. Lipid-laden hepatocyte models such as HepG2 cells or primary hepatocytes treated with free fatty acids are commonly used cellular systems in which the library can be screened for compounds that reduce hepatic lipid accumulation, improve mitochondrial fatty acid oxidation, or modulate key transcriptional regulators such as SREBP-1c and PPARα.
References
- Walther TC, Farese RV Jr. Lipid droplets and cellular lipid metabolism. Annual Review of Biochemistry. 2012;81:687-714. doi:10.1146/annurev-biochem-061009-102430
- Röhrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nature Reviews Cancer. 2016;16(11):732-749. doi:10.1038/nrc.2016.89
- Goldstein JL, Brown MS. A century of cholesterol and coronaries: from plaques to genes to statins. Cell. 2015;161(1):161-172. doi:10.1016/j.cell.2015.01.036
- Aladdin Scientific product page: Lipid Metabolism Compound Library, SKU Lib412096 (Selleck L9200).
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
